Ghost Tree Capital as of June 30, 2019
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 42 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sarepta Therapeutics (SRPT) | 9.1 | $44M | 290k | 151.95 | |
SPDR S&P Biotech (XBI) | 9.1 | $44M | 500k | 87.71 | |
Invesco Qqq Trust Series 1 (QQQ) | 7.8 | $37M | 200k | 186.74 | |
Blueprint Medicines (BPMC) | 7.3 | $35M | 375k | 94.33 | |
Mirati Therapeutics | 7.2 | $35M | 335k | 103.00 | |
Ascendis Pharma A S (ASND) | 5.4 | $26M | 225k | 115.15 | |
Axsome Therapeutics (AXSM) | 4.5 | $22M | 850k | 25.75 | |
ACADIA Pharmaceuticals (ACAD) | 4.2 | $20M | 750k | 26.73 | |
Immunomedics | 4.0 | $19M | 1.4M | 13.87 | |
Amicus Therapeutics (FOLD) | 3.8 | $18M | 1.5M | 12.48 | |
Global Blood Therapeutics In | 3.3 | $16M | 300k | 52.60 | |
Argenx Se (ARGX) | 2.9 | $14M | 100k | 141.58 | |
Alnylam Pharmaceuticals (ALNY) | 2.3 | $11M | 150k | 72.56 | |
BioCryst Pharmaceuticals (BCRX) | 2.0 | $9.5M | 2.5M | 3.79 | |
Ra Pharmaceuticals | 1.9 | $9.0M | 300k | 30.07 | |
Invesco exchange traded (FXF) | 1.8 | $8.8M | 92k | 94.91 | |
Cymabay Therapeutics | 1.5 | $7.2M | 1.0M | 7.16 | |
Rocket Pharmaceuticals (RCKT) | 1.4 | $6.9M | 460k | 15.00 | |
Kalvista Pharmaceuticals (KALV) | 1.4 | $6.6M | 300k | 22.15 | |
Viewray (VRAYQ) | 1.4 | $6.6M | 750k | 8.81 | |
Pfizer (PFE) | 1.4 | $6.5M | 150k | 43.32 | |
Milestone Pharmaceuticals (MIST) | 1.4 | $6.5M | 240k | 27.15 | |
Momenta Pharmaceuticals | 1.3 | $6.2M | 500k | 12.45 | |
Zymeworks | 1.2 | $6.1M | 275k | 22.00 | |
Epizyme | 1.2 | $5.8M | 465k | 12.55 | |
Sage Therapeutics (SAGE) | 1.1 | $5.5M | 30k | 183.10 | |
Spark Therapeutics | 1.1 | $5.1M | 50k | 102.38 | |
Arvinas Ord (ARVN) | 1.0 | $4.9M | 225k | 21.99 | |
Biohaven Pharmaceutical Holding | 0.9 | $4.4M | 100k | 43.79 | |
Kadmon Hldgs | 0.9 | $4.3M | 2.1M | 2.06 | |
Coherus Biosciences (CHRS) | 0.8 | $3.9M | 175k | 22.10 | |
Dicerna Pharmaceuticals | 0.8 | $3.7M | 235k | 15.75 | |
Iovance Biotherapeutics (IOVA) | 0.8 | $3.7M | 150k | 24.52 | |
Orchard Therapeutics Plc ads | 0.7 | $3.4M | 243k | 13.99 | |
Chiasma | 0.6 | $3.0M | 400k | 7.47 | |
Uniqure Nv (QURE) | 0.6 | $2.7M | 35k | 78.14 | |
Homology Medicines | 0.5 | $2.4M | 125k | 19.57 | |
Protagonist Therapeutics (PTGX) | 0.5 | $2.4M | 200k | 12.11 | |
Odonate Therapeutics Ord | 0.5 | $2.4M | 65k | 36.69 | |
ArQule | 0.5 | $2.2M | 200k | 11.01 | |
Solid Biosciences | 0.1 | $575k | 100k | 5.75 | |
Allakos (ALLK) | 0.1 | $455k | 11k | 43.33 |